Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes

British Journal of Pharmacology

Volumn 173, Issue 11, 2016, Pages 1820-1834

  El Bekay, Rajaa ^a,b   Coín Aragüez, Leticia ^a,b   Fernández García, Diego ^a,b   Oliva Olivera, Wilfredo ^a,b   Bernal López, Rosa ^a,b   Clemente Postigo, Mercedes ^a,b   Delgado Lista, Javier ^c   Diaz Ruiz, Alberto ^d   Guzman Ruiz, Rocío ^d   Vázquez Martínez, Rafael ^d   Lhamyani, Said ^a,b   Roca Rodríguez, María Mar ^a,b   Veledo, Sonia Fernandez ^e   Vendrell, Joan ^e   Malagón, María M ^d   Tinahones, Francisco José ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOPHILIN; EXENDIN 4; FATTY ACID BINDING PROTEIN 4; GLUCAGON LIKE PEPTIDE 1; LIPOPROTEIN LIPASE; LIRAGLUTIDE; MESSENGER RNA; METFORMIN; TUMOR NECROSIS FACTOR ALPHA; PEPTIDE; VENOM;

ADIPOCYTE; ADIPOSE TISSUE; ADRP GENE; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; FABP4 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LPL GENE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TNF ALPHA GENE; TREATMENT DURATION; 3T3-L1 CELL LINE; ANIMAL; COMPLICATION; CYTOLOGY; DRUG EFFECTS; GENETIC MARKER; METABOLISM; MORBID OBESITY; MOUSE; PATHOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; GENETIC MARKERS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MICE; OBESITY, MORBID; PEPTIDES; PILOT PROJECTS; PROSPECTIVE STUDIES; VENOMS;

EID: 84964597597     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13481     Document Type: Article

References (57)

1. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015d). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956-5978.
2. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015b). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744-5869.
3. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015e). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024-6109.
4. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, et al., (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729-5143.
5. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, et al., (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110-6202.
6. Azuma K, Rádiková Z, Mancino J, Toledo FG, Thomas E, Kangani C, et al., (2008). Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab 93: 459-464.
7. Baggio LL, Drucker DJ, (2007). Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157.
8. Castro Cabezas M, van Wijk JP, Elte JW, Klop B, (2012). Effects of metformin on the regulation of free fatty acids in insulin resistance: a double-blind, placebo-controlled study. J Nutr Metab 2012: 394623.
9. Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C, (2012). Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem 287: 6421-6430.
10. Connolly BM, Vanko A, McQuade P, Guenther I, Meng X, Rubins D, et al., (2012). Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist. Mol Imaging Biol 14: 79-87.
11. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, et al., (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461-3471.
12. Drucker DJ, (2006). The biology of incretin hormones. Cell Metab 3: 153-1657.
13. Dunning BE, Foley JE, Ahrén B, (2005). (2005) α-cell function in health and desease: influence of glucagon-like pentide-1. Diabetologia 48: 1700-1713.
14. Farmer SR, (2006). Transcriptional control of adipocyte formation. Cell Metab 4: 263-273.
15. Flint A, Raben A, Astrup A, Holst JJ, (1998). Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101: 515-520.
16. Gao J, Ye H, Serrero G, (2000). Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids. J Cell Physiol 182: 297-302.
17. Gealekman O, Gurav K, Chouinard M, Straubhaar J, Thompson M, Malkani S, et al., (2014). Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor binding protein-4. J Biol Chem 289: 18327-18338.
18. Gericke MT, Kosacka J, Koch D, et al., (2009). Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Br J Pharmacol 157: 620-632.
19. Gregoire FM, Smas CM, Sul HS, (1998). Understanding adipocyte differentiation. Physiol Rev 78: 783-809.
20. Gutzwiller P, Drewe J, Goke B, (1999). Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol Regul Integr Comp Physiol 276: R1541-R15447.
21. Gutzwiller JP, Degen L, Heuss L, Beglinger C, (2004). Glucagon-like peptide 1 (GLP-1) and eating. Physiol Behav 82: 17-19.
22. Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, et al., (2014). Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells. Int J Obes (Lond) 38: 1545-1554.
23. Hajer GR, van Haeften TW, Visseren FL, (2008). Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29: 2959-2971.
24. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ, (2001). The biology of white adipocyte proliferation. Obes Rev 2: 239-254.
25. Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM, (1986). Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A 83: 3786-3790.
26. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al., (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
27. Kolditz CI, Langin D, (2010). Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care 13: 377-381.
28. Kreyman B, Williams G, Ghatei MA, Bloom SR, (1987). Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1303.
29. Large V, Peroni O, Letexier D, Ray H, Beylot M, (2004). Review metabolism of lipids in human white adipocyte. Diabetes Metab 30: 294-309.
30. Majumdar ID, Weber HC, (2010). Gastrointestinal regulatory peptides and their effects on fat tissue. Curr Opin Endocrinol Diabetes Obes 17: 51-56.
31. Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, et al., (2001). Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 24: 489-494.
32. Márquez L, Trapote MA, Luque MA, Alcántara AI, Valverde I, Villanueva-Peñacarrillo ML, (1998). Inositolphosphoglycans possibly mediate the GLP-1 effects on rat liver and adipose tissue. Cell Biochem and Function 16: 51-56.
33. Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML, (2001). GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats. Diabetes Nutr Metab 14: 239-244.
34. McIntosh CH, Widenmaier S, Kim SJ, (2009). Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP). Vitam Horm 80: 409-471.
35. Mérida E, Delgado E, Molina LM, Villanueva-Peñacarrillo ML, Valverde I, (1993). Presence of glucagon and glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of human adipose tissue. J Clin Endocrinol Metab 77: 1654-1657.
36. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams LG, (1997). Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol 172: 275-283.
37. Moreno-Navarrete JM, et al., (2012). The l -α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes 61: 281-291.
38. Nathan DM, Schreiber E, Mojsov S, Habener JF, (1992). Insulinotropic action of glucagon like peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 15: 270-276.
39. Nauck MA, Holst JJ, Willms B, Schmiegel W, (1997). Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes 105: 187-195.
40. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., NC-IUPHAR(2014). The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42: D1098-D1106.
41. Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I, (1997). GLP-1(7-36) amide effects on glucose transport and metabolism in rat adipose tissue. Horm Metab Res 9: 417-421.
42. Pulido MR, Rabanal-Ruiz Y, Almabouada F, Díaz-Ruiz A, Burrell MA, Vázquez MJ, et al., (1999). PPARγ is required for the differentiation of adipose tissue in vivo and in-vitro. Mol Cell 4: 611-617.
43. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al., (1999). PPARγ is required for the differentiation of adipose tissue in vivo and in-vitro. Mol Cell 4: 611-617.
44. Ruiz-Grande C, Alarcón C, Mérida E, Valverde I, (1992). Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 13: 13-16.
45. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ, (2004). Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim Biophys Acta 1636: 59-68.
46. Sancho V, Trigo MV, Martín-Duce A, Gonz Lez N, Acitores A, Arnés L, et al., (2006). Effects of GLP-1 on d -glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects. Int J Mol Med 17: 1133-1137.
47. Smirnova E, Goldberg EB, Makarova KS, Lin L, Brown WJ, Jackson CL, (2006). ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep 7: 106-113.
48. Varady KA, Tussing L, Bhutani S, Braunschweig CL, (2009). Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 58: 1096-1101.
49. Vendrell J, El Bekay R, Peral B, García-Fuentes E, Megia A, Macias-Gonzalez M, et al., (2011). Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology 152: 4072-4079.
50. Villanueva-Peñacarrillo ML, Márquez L, González N, Díaz-Miguel M, Valverde I, (2001a). Effect of GLP-1 on lipid metabolism in human adipocytes. Horm Metab Res 33: 73-77.
51. Villanueva-Peñacarrillo ML, Puente J, Redondo A, Clemente F, Valverde I, (2001b). Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models. Endocrine 15: 241-248.
52. Wang Y, Lim K, Normandin M, Zhao X, Cline GW, Ding YS, (2012). Synthesis and evaluation of [(18)F] exendin (9-39) as a potential biomarker to measure pancreatic beta-cell mass. Nucl Med Biol 39: 167-176.
53. Wicki A, Wild D, Storch D, Seemayer C, Gotthardt M, Behe M, et al., (2007). [Lys40(Ahx-DTPA-111In)NH2]-exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Clin Cancer Res 13: 3696-3705.
54. Xie Y, Kang X, Ackerman WE 4th, Belury MA, Koster C, Rovin BH, et al., (2006). Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab 8: 83-93.
55. +-dependent mechanism. FASEB J 12: 1391-1396.
56. Yang J, Ren J, Song J, Liu F, Wu C, Wang X, et al., (2013). Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes. Int J Mol Med 31: 1429-1435.
57. Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, et al., (2006). GLP-1 activation improves β-cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4: 391-406.